Title Use of neutrophil gelatinase-associated lipocalin in manufacture of medicament for prevention or treatment of polycystic kidney disease
Year 2024
Country CA
Inventor HSIEH, HSIU-MEI
Co-inventor WANG, YI-REN ; JIANG, SI-TSE; JENG, WEN-YIH; CHIOU, YUAN-YOW
Cert. No. CA 2952487
Introduction Disclosed is the use of neutrophil gelatinase-associated lipocalin (NGAL) in the manufacture of a medicament for prevention and treatment of polycystic kidney diseases. By administration of NGAL, the lifespan of patients can be prolonged.
Validity 2036/12/19
Domain Medicine and Health
View count: 107